Skip to content

Clinical trials

Phase 2 Liver Cirrhosis, Biliary trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Phase: Phase 2 Country / region: China Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20211
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Unknown status2
Completed1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cascade Pharmaceuticals, Inc1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Gannex Pharma Co., Ltd.1
Mirum Pharmaceuticals, Inc.1
RenJi Hospital1
Sun Yat-sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary6
Cholangitis2
Digestive System Diseases2
Pruritus2
Bile Duct Diseases1
Biliary Tract Diseases1
Cholangitis, Sclerosing1
Dermatitis, Atopic1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.